InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Discover the full record of transactions filed by Bermingham Nessan. Officer active across 2 companies, notably F-star Therapeutics, Inc.. In total, 3 filings have been logged. History available since 20 November 2020. The latest transaction was disclosed on 8 March 2023 (U). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 条申报中的 3 条
Bermingham Nessan is a declarant and a director at F-star Therapeutics, Inc. and Korro Bio, Inc. The 4 filings in the recent sample cover the period from 2021-08-24 to 2023-11-07, with the transaction nature listed as Attribution. Buy and sell amounts are both EUR 0; among the main filings are EUR 658279.9193932532 on 2023-03-09 at F-star Therapeutics, Inc., a 2023-11-07 filing at Korro Bio, Inc. with no amount stated, and two 2021-08-24 filings at F-star Therapeutics, Inc. at EUR 0.